These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29182862)

  • 1. Inhibition of Mammalian 15-Lipoxygenase by Three Ebselen-like Drugs. A QM/MM and MM/PBSA Comparative Study.
    Cebrián-Prats A; Rovira T; Saura P; González-Lafont À; Lluch JM
    J Phys Chem A; 2017 Dec; 121(51):9752-9763. PubMed ID: 29182862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of mammalian 15-lipoxygenases by the anti-inflammatory drug ebselen: dual-type mechanism involving covalent linkage and alteration of the iron ligand sphere.
    Walther M; Holzhütter HG; Kuban RJ; Wiesner R; Rathmann J; Kühn H
    Mol Pharmacol; 1999 Jul; 56(1):196-203. PubMed ID: 10385701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoactivation of an inhibitor of the 12/15-lipoxygenase pathway.
    Herre S; Schadendorf T; Ivanov I; Herrberger C; Steinle W; Rück-Braun K; Preissner R; Kuhn H
    Chembiochem; 2006 Jul; 7(7):1089-95. PubMed ID: 16755628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and biological evaluation of photo-switchable inhibitors.
    Füllbeck M; Michalsky E; Jaeger IS; Henklein P; Kuhn H; Rück-Braun K; Preissner R
    Genome Inform; 2006; 17(1):141-51. PubMed ID: 17503364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione.
    Schewe C; Schewe T; Wendel A
    Biochem Pharmacol; 1994 Jul; 48(1):65-74. PubMed ID: 8043032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
    Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
    ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
    Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
    Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
    Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
    Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds.
    Mishra B; Priyadarsini KI; Mohan H; Mugesh G
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5334-8. PubMed ID: 16919452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of methionine aminopeptidase 2 as a molecular target of the organoselenium drug ebselen and its derivatives/analogues: Synthesis, inhibitory activity and molecular modeling study.
    Węglarz-Tomczak E; Burda-Grabowska M; Giurg M; Mucha A
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5254-5259. PubMed ID: 27692546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebselen: Mechanisms of Glutamate Dehydrogenase and Glutaminase Enzyme Inhibition.
    Yu Y; Jin Y; Zhou J; Ruan H; Zhao H; Lu S; Zhang Y; Li D; Ji X; Ruan BH
    ACS Chem Biol; 2017 Dec; 12(12):3003-3011. PubMed ID: 29072450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitro-, Azo-, and Amino Derivatives of Ebselen: Synthesis, Structure, and Cytoprotective Effects.
    Singh VP; Poon JF; Yan J; Lu X; Ott MK; Butcher RJ; Gates PJ; Engman L
    J Org Chem; 2017 Jan; 82(1):313-321. PubMed ID: 27997177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzoselenazolinone derivatives designed to be glutathione peroxidase mimetics feature inhibition of cyclooxygenase/5-lipoxygenase pathways and anti-inflammatory activity.
    Galet V; Bernier JL; Hénichart JP; Lesieur D; Abadie C; Rochette L; Lindenbaum A; Chalas J; Renaud de la Faverie JF; Pfeiffer B
    J Med Chem; 1994 Sep; 37(18):2903-11. PubMed ID: 8071938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of ebselen and its acyclic derivatives.
    Chang TC; Huang ML; Hsu WL; Hwang JM; Hsu LY
    Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1413-6. PubMed ID: 14646319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.
    Leroux F; Bosc D; Beghyn T; Hermant P; Warenghem S; Landry V; Pottiez V; Guillaume V; Charton J; Herledan A; Urata S; Liang W; Sheng L; Tang WJ; Deprez B; Deprez-Poulain R
    Eur J Med Chem; 2019 Oct; 179():557-566. PubMed ID: 31276900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Selenization of salicylic acid derivatives yielded isoform-specific 5-lipoxygenase inhibitors.
    Yu SC; Kuhn H; Daniliuc CG; Ivanov I; Jones PG; du Mont WW
    Org Biomol Chem; 2010 Feb; 8(4):828-34. PubMed ID: 20135040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxygenase is irreversibly inactivated by the hydroperoxides formed from the enynoic analogues of linoleic acid.
    Nieuwenhuizen WF; Van der Kerk-Van Hoof A; van Lenthe JH; Van Schaik RC; Versluis K; Veldink GA; Vliegenthart JF
    Biochemistry; 1997 Apr; 36(15):4480-8. PubMed ID: 9109655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors.
    Jabbari A; Davoodnejad M; Alimardani M; Assadieskandar A; Sadeghian A; Safdari H; Movaffagh J; Sadeghian H
    Bioorg Med Chem; 2012 Sep; 20(18):5518-26. PubMed ID: 22917856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies of the radical-scavenging activity of ebselen, a seleno-organic compound.
    Fujisawa S; Kadoma Y
    Anticancer Res; 2005; 25(6B):3989-94. PubMed ID: 16309189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.
    Luo Z; Sheng J; Sun Y; Lu C; Yan J; Liu A; Luo HB; Huang L; Li X
    J Med Chem; 2013 Nov; 56(22):9089-99. PubMed ID: 24160297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.